NEW YORK (Reuters Health) - Given what little we know about the immune response to SARS-CoV-2, it remains unclear what role serologic testing for antibodies to the virus should play, according to a commentary. “There is too much uncertainty in serologic ...
from Google Alert - health https://ift.tt/2YrfLWO
via IFTTT
0 comments:
Post a Comment